366 related articles for article (PubMed ID: 29066051)
1. Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT).
Glick D; Lyen S; Kandel S; Shapera S; Le LW; Lindsay P; Wong O; Bezjak A; Brade A; Cho BCJ; Hope A; Sun A; Giuliani M
Clin Lung Cancer; 2018 Mar; 19(2):e219-e226. PubMed ID: 29066051
[TBL] [Abstract][Full Text] [Related]
2. Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer.
Ueki N; Matsuo Y; Togashi Y; Kubo T; Shibuya K; Iizuka Y; Mizowaki T; Togashi K; Mishima M; Hiraoka M
J Thorac Oncol; 2015 Jan; 10(1):116-25. PubMed ID: 25376512
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: the potential risk of extensive radiation pneumonitis.
Yamaguchi S; Ohguri T; Ide S; Aoki T; Imada H; Yahara K; Narisada H; Korogi Y
Lung Cancer; 2013 Nov; 82(2):260-5. PubMed ID: 24054547
[TBL] [Abstract][Full Text] [Related]
4. Predicting risk factors for radiation pneumonitis after stereotactic body radiation therapy for primary or metastatic lung tumours.
Okubo M; Itonaga T; Saito T; Shiraishi S; Mikami R; Nakayama H; Sakurada A; Sugahara S; Koizumi K; Tokuuye K
Br J Radiol; 2017 May; 90(1073):20160508. PubMed ID: 28195507
[TBL] [Abstract][Full Text] [Related]
5. Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease.
Bahig H; Filion E; Vu T; Chalaoui J; Lambert L; Roberge D; Gagnon M; Fortin B; BĂ©liveau-Nadeau D; Mathieu D; Campeau MP
Pract Radiat Oncol; 2016; 6(5):367-374. PubMed ID: 27068780
[TBL] [Abstract][Full Text] [Related]
6. Radiation pneumonitis after palliative radiotherapy in cancer patients with interstitial lung disease.
Okumura M; Hojo H; Nakamura M; Hiyama T; Nakamura N; Zenda S; Motegi A; Hirano Y; Kageyama SI; Parshuram RV; Fujisawa T; Kuno H; Akimoto T
Radiother Oncol; 2021 Aug; 161():47-54. PubMed ID: 34089755
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Radiation Pneumonitis After Stereotactic Body Radiotherapy: Effect of Pulmonary Emphysema Quantitated Using CTÂ Images.
Yamamoto T; Kadoya N; Sato Y; Matsushita H; Umezawa R; Kubozono M; Ishikawa Y; Kozumi M; Takahashi N; Morishita Y; Katagiri Y; Sato K; Ito K; Takeda K; Jingu K
Clin Lung Cancer; 2018 Jan; 19(1):e85-e90. PubMed ID: 28655592
[TBL] [Abstract][Full Text] [Related]
8. Is Thoracic Radiotherapy an Absolute Contraindication for Treatment of Lung Cancer Patients With Interstitial Lung Disease? A Systematic Review.
Saha A; Dickinson P; Shrimali RK; Salem A; Agarwal S
Clin Oncol (R Coll Radiol); 2022 Dec; 34(12):e493-e504. PubMed ID: 35168842
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibitors decrease the risk of radiation pneumonitis after stereotactic body radiation therapy.
Harder EM; Park HS; Nath SK; Mancini BR; Decker RH
Pract Radiat Oncol; 2015; 5(6):e643-9. PubMed ID: 26412341
[TBL] [Abstract][Full Text] [Related]
10. Early graphical appearance of radiation pneumonitis correlates with the severity of radiation pneumonitis after stereotactic body radiotherapy (SBRT) in patients with lung tumors.
Takeda A; Ohashi T; Kunieda E; Enomoto T; Sanuki N; Takeda T; Shigematsu N
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):685-90. PubMed ID: 20510193
[TBL] [Abstract][Full Text] [Related]
11. Severe COPD is correlated with mild radiation pneumonitis following stereotactic body radiotherapy.
Takeda A; Kunieda E; Ohashi T; Aoki Y; Oku Y; Enomoto T; Nomura K; Sugiura M
Chest; 2012 Apr; 141(4):858-866. PubMed ID: 21885726
[TBL] [Abstract][Full Text] [Related]
12. Case Series of 23 Patients Who Developed Fatal Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer.
Onishi H; Marino K; Yamashita H; Terahara A; Onimaru R; Kokubo M; Shioyama Y; Kozuka T; Matsuo Y; Aruga T; Hiraoka M
Technol Cancer Res Treat; 2018 Jan; 17():1533033818801323. PubMed ID: 30286697
[TBL] [Abstract][Full Text] [Related]
13. Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy.
Li F; Zhou Z; Wu A; Cai Y; Wu H; Chen M; Liang S
Radiat Oncol; 2018 May; 13(1):82. PubMed ID: 29716649
[TBL] [Abstract][Full Text] [Related]
14. Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR) - An analysis of UK's largest cohort of lung SABR patients.
Saha A; Beasley M; Hatton N; Dickinson P; Franks K; Clarke K; Jain P; Teo M; Murray P; Lilley J
Radiother Oncol; 2021 Mar; 156():153-159. PubMed ID: 33333139
[TBL] [Abstract][Full Text] [Related]
15. Risk of Pneumonitis After Stereotactic Body Radiation Therapy in Patients With Previous Anatomic Lung Resection.
Hayes JT; David EA; Qi L; Chen AM; Daly ME
Clin Lung Cancer; 2015 Sep; 16(5):379-84. PubMed ID: 25737143
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary dose-volume predictors of radiation pneumonitis following stereotactic body radiation therapy.
Harder EM; Park HS; Chen ZJ; Decker RH
Pract Radiat Oncol; 2016; 6(6):e353-e359. PubMed ID: 27156424
[TBL] [Abstract][Full Text] [Related]
17. The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation.
Ren C; Ji T; Liu T; Dang J; Li G
Radiat Oncol; 2018 Apr; 13(1):69. PubMed ID: 29661254
[TBL] [Abstract][Full Text] [Related]
18. Survival Impact of Cardiac Dose Following Lung Stereotactic Body Radiotherapy.
Wong OY; Yau V; Kang J; Glick D; Lindsay P; Le LW; Sun A; Bezjak A; Cho BCJ; Hope A; Giuliani M
Clin Lung Cancer; 2018 Mar; 19(2):e241-e246. PubMed ID: 28941961
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for radiation pneumonitis in lung cancer patients with subclinical interstitial lung disease after thoracic radiation therapy.
Li F; Liu H; Wu H; Liang S; Xu Y
Radiat Oncol; 2021 Apr; 16(1):70. PubMed ID: 33849579
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Shaverdian N; Veruttipong D; Wang J; Schaue D; Kupelian P; Lee P
Clin Lung Cancer; 2016 Jan; 17(1):39-46. PubMed ID: 26372098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]